Dr. Paul Sorajja, MD
Claim this profileAbbott Northwestern Hospital
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
15 reported clinical trials
25 drugs studied
Affiliated Hospitals
Clinical Trials Paul Sorajja, MD is currently running
TMVR
for Mitral Valve Regurgitation
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Recruiting1 award N/A
Tricuspid Valve Replacement
for Tricuspid Regurgitation
The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding bioprosthetic valve within the tricuspid valve.
Recruiting1 award N/A7 criteria
More about Paul Sorajja, MD
Clinical Trial Related7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Paul Sorajja, MD has experience with
- Portico™ NG Valve And FlexNav™ Delivery System
- Portico™ NG (Navitor) Valve And FlexNav™ Delivery System
- Navitor Titan Valve (35mm) Valve And Large FlexNav™ Delivery System
- Tendyne Mitral Valve System
- MitraClip System
- Millipede Transcatheter Annuloplasty Ring System
Breakdown of trials Paul Sorajja, MD has run
Mitral Regurgitation
Mitral Valve Regurgitation
Valvular Heart Disease
Aortic Stenosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Sorajja, MD specialize in?
Paul Sorajja, MD focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved Stage III patients, or patients who are undergoing treatment.
Is Paul Sorajja, MD currently recruiting for clinical trials?
Yes, Paul Sorajja, MD is currently recruiting for 5 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Paul Sorajja, MD has studied deeply?
Yes, Paul Sorajja, MD has studied treatments such as Portico™ NG Valve and FlexNav™ Delivery System, Portico™ NG (Navitor) Valve and FlexNav™ Delivery System, Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System.
What is the best way to schedule an appointment with Paul Sorajja, MD?
Apply for one of the trials that Paul Sorajja, MD is conducting.
What is the office address of Paul Sorajja, MD?
The office of Paul Sorajja, MD is located at: Abbott Northwestern Hospital, Minneapolis, Minnesota 55407 United States. This is the address for their practice at the Abbott Northwestern Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.